Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been assessed by a doctor as having suspected neurological movement disorder (parkinsonism) that may be related to Parkinson's disease or a related condition, showing slowness of movement plus at least one of: muscle stiffness or a tremor at rest.
- People aged between 40 and 80 years.
- People who have given written agreement to take part in the study.
- People whose movement disorder symptoms have been present for less than 3 years.
- People who have had a specific brain imaging scan (called a DaTscan) that showed an abnormal result, confirming damage to a particular group of nerve cells involved in movement control.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have not given consent to take part in the study.
- People whose parkinsonism is caused by another condition or by medication rather than a neurodegenerative disease.
- People who have another brain or nervous system condition (such as a tumour or stroke-related changes) that could explain their symptoms.
- People who currently have an active cancer, active infection, or an active autoimmune or inflammatory disease.
- People who have serious ongoing health conditions, including severe heart failure, poorly controlled diabetes, significant kidney disease, or liver failure (confirm with trial site for specific medical thresholds).
- People who carry a known genetic mutation that is a known cause of parkinsonism, as listed in a specific international genetic database (OMIM).
- People who have taken antibiotics or probiotic supplements in the 3 months before their study visit.
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jacek Kuźnicki, The International Institute of Molecular and Cell Biology in Warsaw
Phone: +48 22 5970700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Differential expression of selected microRNAs; Differences in metabolomic profiles
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.